MSB 1.90% $1.61 mesoblast limited

Just gets better and better and better The study’s lead...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,300 Posts.
    lightbulb Created with Sketch. 6
    Just gets better and better and better

    The study’s lead investigator, Robert Sackstein, MD, PhD, Professor of Medicine at Harvard Medical
    School, said: “The hypothesis was that inflammation that destroys pancreatic islet cells could be
    controlled by selectively targeting the pancreas with anti-inflammatory mesenchymal lineage
    cells. The realization was that this new clinical approach essentially cured mice of Type 1 diabetes.”
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.61
Change
0.030(1.90%)
Mkt cap ! $1.832B
Open High Low Value Volume
$1.65 $1.65 $1.59 $7.014M 4.343M

Buyers (Bids)

No. Vol. Price($)
1 342 $1.61
 

Sellers (Offers)

Price($) Vol. No.
$1.61 54534 8
View Market Depth
Last trade - 16.10pm 19/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.